• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性胸主动脉夹层的基质金属蛋白酶水平。

Matrix metalloproteinase levels in chronic thoracic aortic dissection.

机构信息

Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Texas; Department of Pathophysiology, Shandong University School of Medicine, Jinan, Shandong, China.

Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Texas; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas.

出版信息

J Surg Res. 2014 Jun 15;189(2):348-58. doi: 10.1016/j.jss.2014.03.027. Epub 2014 Mar 19.

DOI:10.1016/j.jss.2014.03.027
PMID:24746253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4065027/
Abstract

BACKGROUND

Imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) can lead to aortic wall failure. We hypothesized that patients with aneurysms resulting from chronic descending thoracic aortic dissection have elevated tissue and plasma levels of specific MMPs and decreased tissue levels of TIMPs.

MATERIALS AND METHODS

Aortic tissue was obtained from 25 patients who required surgical repair of descending thoracic aortic aneurysm due to chronic aortic dissection and from 17 organ-donor controls without aortic disease. Tissue levels of MMP-1, -2, -3, -9, -12, and -13 and TIMP-1 and -2 were measured by colorimetric activity assay or enzyme-linked immunosorbent assay and confirmed by Western blot and immunohistochemistry. Blood obtained from the 25 patients and 15 controls without aortic diseases was used to compare plasma levels of MMP-3, -9, and -12.

RESULTS

Total MMP-1, total MMP-9, and active MMP-9 levels were higher and total MMP-2 levels were lower in dissection tissue than in control tissue. Additionally, the MMP-9 to TIMP-1 and active to total MMP-2 ratios were higher and the MMP-2 to TIMP-2 ratio was lower in dissection tissue. Furthermore, patients had higher plasma active to total MMP-9 ratios than the controls. Age and hypertension were associated with increased MMP levels.

CONCLUSIONS

Increased levels of several MMPs and increased MMP to TIMP ratios in aortic tissue from patients suggest an environment that favors proteolysis, which may promote progressive extracellular matrix destruction and medial degeneration after aortic dissection. An elevated active to total MMP-9 ratio in plasma may be a biomarker for end-stage aneurysm development in patients with chronic thoracic aortic disease.

摘要

背景

基质金属蛋白酶(MMPs)与基质金属蛋白酶抑制剂(TIMPs)之间的失衡可导致主动脉壁衰竭。我们假设,由于慢性降主动脉夹层引起的动脉瘤患者,其组织和血浆中特定 MMP 的水平升高,而组织中 TIMP 的水平降低。

材料和方法

从 25 名因慢性主动脉夹层而行降主动脉瘤外科修复的患者和 17 名无主动脉疾病的器官供体对照者中获得主动脉组织。通过比色活性测定法或酶联免疫吸附测定法测量 MMP-1、-2、-3、-9、-12 和 -13 以及 TIMP-1 和 -2 的组织水平,并通过 Western blot 和免疫组织化学进行验证。从 25 名患者和 15 名无主动脉疾病的对照者中获得的血液用于比较 MMP-3、-9 和 -12 的血浆水平。

结果

与对照组织相比,夹层组织中的总 MMP-1、总 MMP-9 和活性 MMP-9 水平更高,总 MMP-2 水平更低。此外,夹层组织中 MMP-9 与 TIMP-1 的比值和活性 MMP-2 与总 MMP-2 的比值更高,而 MMP-2 与 TIMP-2 的比值更低。此外,患者的血浆中活性与总 MMP-9 的比值高于对照组。年龄和高血压与 MMP 水平的升高有关。

结论

主动脉组织中几种 MMP 水平升高和 MMP 与 TIMP 比值升高提示有利于蛋白水解的环境,这可能促进主动脉夹层后的细胞外基质进行性破坏和中膜退变。血浆中升高的活性与总 MMP-9 比值可能是慢性胸主动脉疾病患者终末期动脉瘤发展的生物标志物。

相似文献

1
Matrix metalloproteinase levels in chronic thoracic aortic dissection.慢性胸主动脉夹层的基质金属蛋白酶水平。
J Surg Res. 2014 Jun 15;189(2):348-58. doi: 10.1016/j.jss.2014.03.027. Epub 2014 Mar 19.
2
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.组织微阵列基质金属蛋白酶表达增加有利于胸主动脉瘤和夹层中的蛋白水解。
Ann Thorac Surg. 2004 Dec;78(6):2106-10; discussion 2110-1. doi: 10.1016/j.athoracsur.2004.05.088.
3
Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection.A型和B型主动脉夹层急性期及亚急性期血浆中金属蛋白酶-9和-2的水平
J Cardiovasc Med (Hagerstown). 2006 May;7(5):307-15. doi: 10.2459/01.JCM.0000223251.26988.c5.
4
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.胸主动脉疾病和急性心肌缺血患者血清基质金属蛋白酶-1、-2、-3和-9水平
J Cardiothorac Surg. 2009 Nov 3;4:59. doi: 10.1186/1749-8090-4-59.
5
Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.用于区分胸主动脉瘤疾病病因亚型的血浆生物标志物。
J Thorac Cardiovasc Surg. 2013 May;145(5):1326-33. doi: 10.1016/j.jtcvs.2012.12.027. Epub 2013 Jan 11.
6
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.血浆基质金属蛋白酶及其组织抑制剂水平与肺结核患者不良治疗结局的相关性。
JAMA Netw Open. 2020 Dec 1;3(12):e2027754. doi: 10.1001/jamanetworkopen.2020.27754.
7
Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.严重脓毒症中基质金属蛋白酶及其组织抑制剂的动态变化。
J Crit Care. 2011 Dec;26(6):550-5. doi: 10.1016/j.jcrc.2011.02.011. Epub 2011 May 6.
8
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌金属蛋白酶及其组织抑制剂在肌萎缩侧索硬化症患者血清和脑脊液中的变化。
Eur J Neurol. 2010 Feb;17(2):226-31. doi: 10.1111/j.1468-1331.2009.02775.x. Epub 2009 Oct 1.
9
The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection.血浆基质金属蛋白酶-8在急性胸主动脉夹层中的显著表达。
J Surg Res. 2010 Oct;163(2):e99-104. doi: 10.1016/j.jss.2010.05.030. Epub 2010 Jun 9.
10
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.痴呆患者血浆中基质金属蛋白酶及其抑制剂的概况
Int Psychogeriatr. 2008 Feb;20(1):67-76. doi: 10.1017/S1041610207005790. Epub 2007 Aug 15.

引用本文的文献

1
Matrix metalloproteinases and their tissue inhibitors as indicators of aortic aneurysm and dissection development in extracellular matrix remodeling.基质金属蛋白酶及其组织抑制剂作为细胞外基质重塑中主动脉瘤和主动脉夹层发展的指标。
World J Exp Med. 2025 Jun 20;15(2):100166. doi: 10.5493/wjem.v15.i2.100166.
2
A Narrative Review of Biomarkers and Imaging in the Diagnosis of Acute Aortic Syndrome.急性主动脉综合征诊断中生物标志物与影像学的叙述性综述
Diagnostics (Basel). 2025 Jan 14;15(2):183. doi: 10.3390/diagnostics15020183.
3
Circulating Matrix Metalloproteinases for Prediction of Aortic Dilatation in Children with Bicuspid Aortic Valve: A Single-Center, Observational Study.

本文引用的文献

1
Matrix metalloproteinases in vascular physiology and disease.基质金属蛋白酶在血管生理与疾病中的作用
Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15.
2
Deaths: leading causes for 2008.死亡:2008年的主要死因。
Natl Vital Stat Rep. 2012 Jun 6;60(6):1-94.
3
Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.涉及细胞外基质重塑和腹主动脉瘤的基因多态性。
循环基质金属蛋白酶在预测二叶式主动脉瓣患儿主动脉扩张中的作用:一项单中心观察性研究。
Int J Mol Sci. 2024 Sep 30;25(19):10538. doi: 10.3390/ijms251910538.
4
Using Molecular Targets to Predict and Treat Aortic Aneurysms.利用分子靶点预测和治疗主动脉瘤。
Rev Cardiovasc Med. 2022 Sep 13;23(9):307. doi: 10.31083/j.rcm2309307. eCollection 2022 Sep.
5
Long-Term Outcomes of Endovascular Treatment for Type B Aortic Dissection with Simple Renal Cysts: A Multicenter Retrospective Study.伴有单纯肾囊肿的B型主动脉夹层腔内治疗的长期预后:一项多中心回顾性研究
Rev Cardiovasc Med. 2022 Jun 24;23(7):226. doi: 10.31083/j.rcm2307226. eCollection 2022 Jul.
6
Expression of , , and genes in aortic dissection.、、和基因在主动脉夹层中的表达。
Exp Ther Med. 2024 Jul 10;28(3):360. doi: 10.3892/etm.2024.12649. eCollection 2024 Sep.
7
Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections.揭示胸主动脉瘤和夹层的细胞和分子方面。
Basic Res Cardiol. 2024 Jun;119(3):371-395. doi: 10.1007/s00395-024-01053-1. Epub 2024 May 3.
8
Roles of pyroptosis and immune infiltration in aortic dissection.细胞焦亡与免疫浸润在主动脉夹层中的作用。
Front Mol Biosci. 2024 Mar 19;11:1277818. doi: 10.3389/fmolb.2024.1277818. eCollection 2024.
9
The Role of Matrix Metalloproteinases in Thoracic Aortic Disease: Are They Indicators for the Pathogenesis of Dissections?基质金属蛋白酶在胸主动脉疾病中的作用:它们是夹层发病机制的指标吗?
Biomedicines. 2024 Mar 9;12(3):619. doi: 10.3390/biomedicines12030619.
10
Downregulation of LILRB4 Promotes Human Aortic Smooth Muscle Cell Contractile Phenotypic Switch and Apoptosis in Aortic Dissection.LILRB4 的下调促进主动脉夹层中血管平滑肌细胞收缩表型转换和凋亡。
Cardiovasc Toxicol. 2024 Mar;24(3):225-239. doi: 10.1007/s12012-023-09824-3. Epub 2024 Feb 7.
J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.
4
Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms.同型半胱氨酸与基质金属蛋白酶-3、-9 在升主动脉瘤患者中的表达。
Thromb Res. 2011 Nov;128(5):e95-9. doi: 10.1016/j.thromres.2011.07.008. Epub 2011 Jul 29.
5
Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach.人腹主动脉瘤细胞外基质组成和重塑:蛋白质组学方法。
Mol Cell Proteomics. 2011 Aug;10(8):M111.008128. doi: 10.1074/mcp.M111.008128. Epub 2011 May 18.
6
Markers of proteolysis, fibrinolysis, and coagulation in relation to size and growth rate of abdominal aortic aneurysms.与腹主动脉瘤大小和生长速率相关的蛋白水解、纤维蛋白溶解及凝血标志物。
Vasc Endovascular Surg. 2010 May;44(4):262-8. doi: 10.1177/1538574410361971. Epub 2010 Mar 30.
7
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.胸主动脉疾病和急性心肌缺血患者血清基质金属蛋白酶-1、-2、-3和-9水平
J Cardiothorac Surg. 2009 Nov 3;4:59. doi: 10.1186/1749-8090-4-59.
8
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.血浆基质金属蛋白酶水平不能预测适合择期修复的腹主动脉瘤组织水平。
Vascular. 2008 Sep-Oct;16(5):248-52. doi: 10.2310/6670.2008.00043.
9
Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture--a systematic review.腹主动脉瘤扩张和破裂的潜在循环生物标志物——一项系统评价
Eur J Vasc Endovasc Surg. 2008 Sep;36(3):273-80; discussion 281-2. doi: 10.1016/j.ejvs.2008.05.009. Epub 2008 Jul 17.
10
Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture.血浆中基质金属蛋白酶1(MMP1)和基质金属蛋白酶9(MMP9)水平升高与腹主动脉瘤破裂有关。
Eur J Vasc Endovasc Surg. 2008 May;35(5):580-4. doi: 10.1016/j.ejvs.2007.12.004. Epub 2008 Jan 15.